ALKERMES | ALKS - 이자 수익

주가
33.31
매일 변경
-0.60 -1.77%
매월
13.42%
매년
19.65%
Q2 예상
32.32




이자 수익 변화 날짜
AbbVie USD 72M 10M 2025-09
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
ALKERMES USD 11.94M 853K 2025-09
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 7M 2025-12
Heron Therapeutics USD 433K 277K 2021-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.14 237M 2026-03
Merck USD 96M 27M 2025-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Otsuka Holdings JPY 10.49B 396M 2024-06
Pfizer USD 0.62 156M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09